Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pro Cure AS
AS
Active
Org 983180949
Myklerudveien 144, 1454
Fagerstrand
Veterinary activities
·
NACE 7500
Est. 2001 · 25 years old
2 employees
www.procure.as
Monitor
Share
Norway
/
Companies
/
Veterinary activities
/
Pro Cure AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 2M (+100% vs 2020)
2M
+100%
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 976
2 365
2 499
2 081
1 488
Staff expenses
−1 314
−1 224
−1 278
−947
−430
EBITDA
−27
320
283
196
201
Depreciation & amort.
−38
−209
−179
−158
−248
EBIT
−64
111
105
38
−47
Net financials
50
−31
−5
29
−42
Profit before tax
−14
81
100
67
−89
Tax
−15
−106
−0
−0
−0
Net profit
1
187
100
67
−89
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
925
1 478
1 534
1 158
1 093
Equity
556
555
468
368
301
Long-term debt
0
0
0
0
0
Short-term debt
370
923
1 066
790
792
Total debt
370
923
1 066
790
792
Financial ratios
5-year trend
EBITDA margin
−1,3 %
This company
15,8 %
Market median
This company
Market median
108% below market
2020
2024
Equity ratio
60,0 %
This company
38,2 %
Market median
This company
Market median
57% above market
2020
2024
Return on equity
0,2 %
This company
18,4 %
Market median
This company
Market median
99% below market
2020
2024
Net profit margin
0,1 %
This company
8,1 %
Market median
This company
Market median
99% below market
2020
2024
Asset turnover
2,14×
This company
1,12×
Market median
This company
Market median
91% above market
2020
2024
Debt / equity
0,67×
This company
0,62×
Market median
This company
Market median
8% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pro Cure AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
